Skip to content

Effect of Omega 3 Fats on Sperm Quality and Sexual Function

Effect of Omega 3 Fats on Sperm Quality and Sexual Function in Infertile Men Age 35-55

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00406874
Enrollment
6
Registered
2006-12-04
Start date
2007-01-31
Completion date
2007-12-31
Last updated
2013-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

infertility, semen quality, sexual function, blood pressure, omega 3 fats, folic acid

Brief summary

This study compares the effects of omega 3 fats plus folic acid with placebo plus folic acid on sperm quality and sexual function in infertile men. It will also evaluate the effects on sexual fuction of a sub-therapeutic dose of a PDE 5 inhibitor versus placebo in subjects continuing on both omega 3 fats and folic acid.

Detailed description

Infertile men commonly have difficulty timing sexual relations around the time of ovulation. There is a high incidence of abnormal sperm morphology in infertile men. Omega 3 fats are known to increase the production of nitric oxide, which is the mediator of the male response, and folic acid is an important cofactor in the production of nitric oxide. Omega 3 fats are also important in the structure and function of cell membranes. There is a high incidence of deficient intake of omega 3 fats and folic acid in the U.S. population. Both folic acid and omega 3 fats are available as nutritional supplements and the doses used in this study are doses commonly recommended as nutritional supplements. Comparison: Omega 3 fats plus folic acid will be compared with placebo plus folic acid in men age 35 to 55 attempting pregnancy with normal or mildly impaired semen quality. They will fill out dietary questionaires, questionaires regarding sexual function, and will have measurements of serum nitrates, blood pressure, and semen quality before and during use of these nutritional supplements. In men continuing on both omega 3 fats and folic acid, we will compare the effects of a sub-therapeutic dose of a PDE 5 inhibitor versus placebo on their sexual function.

Interventions

DRUGomega 3 fats

1,000 mg daily

DRUGfolic acid

800 micrograms daily

Sponsors

Reproductive Partners Medical Group
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
35 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* infertile men * age 35 to 55 * expressing difficulty timing relations to their partner's ovulation

Exclusion criteria

* hypertension, heart disease or other systemic diseases * fatty fish intake more than twice per week * marked semen abnormalities (less than 10 million sperm per ml, less than 20 % A plus B motility, more than 1 million WBC per HPF) * use of anticoagulants * must be willing to not take PDE 5 inhibitors during the study * use of other supplements is prohibited during the study

Design outcomes

Primary

MeasureTime frame
Questionaires regarding sexual functionevery 30 days
Semen analysisevery 30 days

Secondary

MeasureTime frame
blood pressureevery 30 days
serum nitrate levelsevery 30 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026